MedTrace Logo

Interstitial Lung Abnormalities in Renal Transplant Recipients

NCT01017757 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2009-11-23

No results posted yet for this study

Summary

Immunosuppressive drugs such as tacrolimus, cyclosporine, mycophenolate mofetil, sirolimus and everolimus may have toxic pulmonary effects, particularly interstitial alterations. The aim of the present study is to explore the presence of subclinical interstitial lung abnormalities in stable renal transplant recipients taking the different immunosuppressive drugs used as maintenance therapy for renal transplantation.

Conditions

  • Renal Transplantation
  • Kidney-pancreas Transplantation

Interventions

PROCEDURE

High-resolution CT scanning

High-resolution CT scanning

Sponsors & Collaborators

  • University of Parma

    lead OTHER

Principal Investigators

  • Carlo Buzio, MD · University of Parma

Eligibility

Min Age
18 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-10-31
Completion
2009-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017757 on ClinicalTrials.gov